Already a DIA Member? Sign in. Not a member? Join.

Sign in

Forgot User ID? or Forgot Password?

Not a Member?

Create Account and Join

Menu Back to Builders
DIA 2026 for

Builders

Build faster. Build smarter. Build with the finish line in mind.

Scientists · Clinical Researchers · Medical Affairs · Regulatory Scientists · R&D Leaders

Event DIA 2026 Global Annual Meeting
Dates June 14–18, 2026
Location Philadelphia, PA

Regulator-led sessions fill quickly. Use the searchable program to identify regulatory speakers in your therapeutic area and pre-schedule conversations before you arrive.

Explore the Agenda
About This Experience

You're doing the work. DIA 2026 shows you how it lands on the other side.

Breakthroughs don't happen in isolation. The path from discovery to patients runs through clinical operations, regulatory science, data strategy, and quality systems—and the people at every stage of that path are here.

At DIA 2026, you'll hear directly from the regulators who review your submissions and the patients who will use your science. Walk in with the questions you can't answer from inside your organization. Leave with the answers.

What You Gain at DIA 2026

Four reasons Builders make DIA a priority

Regulatory Clarity

Hear What Matters Most

Gain direct insight into what’s working in submissions, where dossiers break down, and how guidance is evolving—so you can reduce avoidable delays and costly cycles." Note that a "reviewer" is a specific role within an regulatory agency and I am not sure if we will have them at the meeting.

Scientific Peer Exchange

Cross-Pollination Unique to This Forum

DIA brings together clinical researchers, regulatory scientists, and medical affairs professionals across therapeutic areas. The cross-pollination of methodology and approach is unique to this annual forum.

Therapeutic Area Navigation

Compare Notes on What's Actually Working

Oncology, personalized medicine, combination products, cell and gene therapy—the Builders working on what's next gather here to compare notes on what's actually working.

Data & Technology Fluency

Evaluate What Tools to Adopt and How

From real-world evidence to AI in clinical trials, DIA 2026's content on data strategy is built for the scientists and operations leaders who need to make decisions about what tools to adopt and how.

Cross-Disciplinary Engagement

The people across the table from your work are here

Regulators (at the meeting, not in a briefing)

FDA, EMA, PMDA, and global health authority representatives participate actively in DIA 2026—in sessions, roundtables, and on the show floor. The direct dialogue between Builders and regulators is the most distinctive feature of this meeting. The conversations that happen here don't happen anywhere else.

Decision Makers (your leadership)

Your C-suite and senior directors are in the room. DIA 2026 creates rare overlap between those doing the science and those setting the strategy—a chance to align on pipeline priorities and surface what leadership needs to understand about the work.

Operators (the people executing alongside you)

Regulatory affairs, quality, and clinical operations teams bring a compliance and execution lens to the science. Builders who engage with Operators at DIA often return with clearer submission timelines and fewer late-stage surprises.

Accelerators (your funders and future partners)

Investors and BD leaders are evaluating the science landscape in real time at DIA. This is an opportunity to tell your story to the people who fund the next phase—before a formal process begins.

Navigate the Meeting
Guidance for Builders: Builders have the deepest content alignment at DIA 2026. With 10 tracks spanning every dimension of medical product development, the challenge is focus—not coverage.

Priority Tracks

Track 2 Clinical Trial Operations and Innovation
Track 5 Personalized Medicine, Combination Products and Diagnostics
Track 3 Data, Technology and AI
Track 7 Regulatory CMC and Product Quality

Track 2 covers clinical trial innovation—methodology, operations, and technology. Track 5 is the home for novel modalities and personalized medicine. Track 7 addresses regulatory CMC and product quality. Track 3 surfaces AI and data strategy implications directly relevant to R&D decision-making.

Explore Full Agenda →

Formats to Seek Out

  • Short Courses — deep-dive workshops on specific technical topics, offered as pre-conference and elaborated further in meeting sessions
  • Poster sessions — the best cross-disciplinary scientific exchange format at DIA; plan significant time here
  • Community Roundtable Discussions — small-group conversations on pressing questions in your field
  • Regulator-led sessions — prioritize these; they fill quickly and offer access not available in any other format
  • DIA Celebrate (Wednesday, June 17) — maximize the connections you made throughout the week at this capstone event at the National Constitution Center

Networking Guidance

Use the searchable program to identify regulatory speakers in your therapeutic area before arriving. Prioritizing those sessions and engaging in the right settings can be one of the highest-value uses of your DIA experience.

Featured Program for Builders

Short Courses

Short Courses are intensive, pre-conference and in-meeting workshops built for deep technical immersion. For Builders, these are the highest-density learning experiences at DIA 2026—structured around specific submission challenges, clinical trial methodologies, quality systems, and emerging modalities. Register separately and early; these workshops have limited enrollment.


Registration Rates

Back to DIA 2026

Back to DIAglobal.org

Be informed and stay engaged.

Don't miss an opportunity - join our mailing list to stay up to date on DIA insights and events.